ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,391.47
-0.39%
Dow Jones
39,806.77
0.00%
Gold vs US Dollar
2,423.165
-0.14%
Brent Oil
82.09
-1.72%
Bitcoin
71,074.38
-0.52%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Bellerophon Therapeutics Inc (BLPH)

  7. Bellerophon Therapeutics Inc (BLPH) News

Bellerophon Therapeutics (BLPH)

Bellerophon Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BLPH
DateTimeSourceHeadlineSymbolCompany
30/01/202414:29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLPHBellerophon Therapeutics Inc
26/01/202419:31Edgar (US Regulatory)Form SCHEDULE 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:BLPHBellerophon Therapeutics Inc
26/01/202415:46Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:BLPHBellerophon Therapeutics Inc
22/01/202420:21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLPHBellerophon Therapeutics Inc
10/01/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLPHBellerophon Therapeutics Inc
03/01/202418:49Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:BLPHBellerophon Therapeutics Inc
27/10/202315:50Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:BLPHBellerophon Therapeutics Inc
17/10/202301:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BLPHBellerophon Therapeutics Inc
16/10/202318:59Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:BLPHBellerophon Therapeutics Inc
16/10/202318:59Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLPHBellerophon Therapeutics Inc
16/10/202318:58Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLPHBellerophon Therapeutics Inc
16/10/202318:58Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLPHBellerophon Therapeutics Inc
16/10/202318:57Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLPHBellerophon Therapeutics Inc
16/10/202318:56Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLPHBellerophon Therapeutics Inc
16/10/202318:56Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLPHBellerophon Therapeutics Inc
16/10/202318:55Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLPHBellerophon Therapeutics Inc
16/10/202318:54Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLPHBellerophon Therapeutics Inc
13/10/202315:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLPHBellerophon Therapeutics Inc
13/10/202313:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLPHBellerophon Therapeutics Inc
14/08/202321:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BLPHBellerophon Therapeutics Inc
07/08/202321:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLPHBellerophon Therapeutics Inc
24/07/202321:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLPHBellerophon Therapeutics Inc
20/07/202321:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLPHBellerophon Therapeutics Inc
14/07/202321:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLPHBellerophon Therapeutics Inc
29/06/202321:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BLPHBellerophon Therapeutics Inc
29/06/202321:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLPHBellerophon Therapeutics Inc
12/06/202311:45Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:BLPHBellerophon Therapeutics Inc
09/06/202321:13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BLPHBellerophon Therapeutics Inc
09/06/202321:12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BLPHBellerophon Therapeutics Inc
09/06/202321:12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BLPHBellerophon Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:BLPH

Your Recent History

UNSW3
ETHMNYETH
Ethereum Money
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved